OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 92 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 13.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $220,000 | +40.1% | 11,600 | 0.0% | 0.00% | – |
| Q4 2018 | $157,000 | -88.9% | 11,600 | -96.0% | 0.00% | – |
| Q4 2016 | $1,412,000 | -0.8% | 288,550 | +0.5% | 0.00% | – |
| Q3 2016 | $1,424,000 | -1.9% | 287,175 | +1.0% | 0.00% | – |
| Q2 2016 | $1,451,000 | -13.5% | 284,312 | -3.3% | 0.00% | – |
| Q1 2016 | $1,677,000 | -42.9% | 294,046 | +3.9% | 0.00% | – |
| Q4 2015 | $2,935,000 | -43.7% | 282,929 | +0.1% | 0.00% | -100.0% |
| Q3 2015 | $5,216,000 | -7.4% | 282,533 | -2.4% | 0.00% | 0.0% |
| Q2 2015 | $5,634,000 | +13.0% | 289,508 | +2.1% | 0.00% | 0.0% |
| Q1 2015 | $4,986,000 | +12.7% | 283,459 | +2.4% | 0.00% | – |
| Q4 2014 | $4,425,000 | +27.7% | 276,753 | +0.7% | 0.00% | – |
| Q3 2014 | $3,466,000 | -20.0% | 274,939 | -0.9% | 0.00% | – |
| Q2 2014 | $4,335,000 | +17.2% | 277,523 | -1.5% | 0.00% | – |
| Q1 2014 | $3,700,000 | -44.1% | 281,795 | -46.7% | 0.00% | – |
| Q4 2013 | $6,616,000 | +48.6% | 529,172 | +97.8% | 0.00% | -100.0% |
| Q3 2013 | $4,452,000 | +73.5% | 267,524 | +5.0% | 0.00% | – |
| Q2 2013 | $2,566,000 | – | 254,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|